Hours of Sleep and Myocardial Infarction Risk

This is one of the first studies to prospectively assess this association, and its outcomes support the idea that poor sleep is a potential MI risk factor. 

Cantidad de horas de sueño y riesgo de infarto de miocardio

Even though we need further data to be able to modify the current sleep duration standards as part of life-style change recommendations, it seems reasonable to start bearing this in mind.

Prior observational studies have associated extremes of sleep duration (both little and too much sleep) with MI risk, but confounders have made it hard to reach a definite conclusion. 

This study assessed 461347 participants free of heart disease, classified into three groups according to reported average sleep duration (short sleep <6 hours, between 6 and 9 hours and long sleep >9 hours). Multiple confounders were assessed, even a genetic disposition for heart disease. 


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


Compared against individuals sleeping between 6 and 9 hours, those reporting short sleep had 20% higher MI risk after adjusting for multiple variables (HR: 1.20; CI 95%: 1.07 to 1.33) and those reporting long sleep had 34% higher risk of MI (HR: 1.34; CI 95%: 1.13 to 1.58).

Conclusion

This prospective study looking at sleep duration and MI risk showed a significant association between the two in people sleeping both short and long hours. More data are needed for us to be able to make recommendations to patients as part of a prevention strategy.

Original title: Sleep Duration and Myocardial Infarction.

Reference: Iyas Daghlas et al. J Am Coll Cardiol 2019;74:1304–14.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...